mitoxantrone has been researched along with Cystadenocarcinoma, Papillary in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Cystadenocarcinoma, Papillary: An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone was infused continuously in 21-day courses beginning every 6 weeks." | 2.68 | Continuous mitoxantrone infusion in pretreated epithelial ovarian cancer. ( Aversa, S; Azzoni, P; Endrizzi, L; Fiorentino, MV; Koussis, H; Nicoletto, MO; Padrini, R; Palumbo, M; Rosabian, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicoletto, MO | 1 |
| Padrini, R | 1 |
| Koussis, H | 1 |
| Rosabian, A | 1 |
| Aversa, S | 1 |
| Endrizzi, L | 1 |
| Azzoni, P | 1 |
| Palumbo, M | 1 |
| Fiorentino, MV | 1 |
1 trial available for mitoxantrone and Cystadenocarcinoma, Papillary
| Article | Year |
|---|---|
Continuous mitoxantrone infusion in pretreated epithelial ovarian cancer.
Topics: Adult; Aged; CA-125 Antigen; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Cystade | 1995 |